pharmaceutical compositions comprising erythropoietin are provided for treatment of cancer , particularly for treatment of multiple myeloma . erythropoietin was found to be effective for inhibition of tumor growth , triggering of tumor regression , stimulation of the natural immunological defense against cancer and / or inhibition of cancer cell metastasis .